Lucira Health Inc
NASDAQ:LHDX
Lucira Health Inc
Revenue
Lucira Health Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
L
|
Lucira Health Inc
NASDAQ:LHDX
|
Revenue
$93.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Lucira Health Inc
Revenue Breakdown
Breakdown by Geography
Lucira Health Inc
Total Revenue:
93.1m
USD
|
United States:
74.8m
USD
|
Canada:
13.1m
USD
|
All Other Countries:
5.2m
USD
|
Breakdown by Segments
Lucira Health Inc
See Also
What is Lucira Health Inc's Revenue?
Revenue
93.1m
USD
Based on the financial report for Dec 31, 2021, Lucira Health Inc's Revenue amounts to 93.1m USD.
What is Lucira Health Inc's Revenue growth rate?
Revenue CAGR 1Y
34 365%
Over the last year, the Revenue growth was 34 365%.